AzTrials
AzTrials

Serious Mental IllnessACNCT07529509

Abriendo Caminos: Engaging Latinos

A study testing Culturally responsive motivational interviewing in people with Serious Mental Illness, run by Yale University at 2 sites in United States.

Recruiting

Looking for participants now. Contact the study team or a site below to ask about taking part.

Sites and contacts
Official record
Search all trials

Trial summary

The goal of this clinical trial is to learn if a culturally responsive peer-delivered motivational interviewing intervention can enhance mental health treatment engagement in Latinos with serious mental illness. Read more about this study

Who is it for?
Ages 18 years and older
Conditions the study is for
Serious Mental Illness
What is being tested?
Culturally responsive motivational interviewing
Could I receive a placebo?
No, everyone receives an active treatment
How many people
30 participants
Where
2 sitesUnited States
Study dates
9 Jul 2026to Aug 2027
Phase
Interventional
Are there results?
Not yet: the study is under way

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Who may be able to join

  • Meet criteria for serious mental illness
  • Not in treatment
  • 18 years of age or older
  • Reside in CT
  • Self-identify as Latino
  • Speak English and/or Spanish
Show all 9Show fewer
  • History of trauma
  • Have not received any treatment in the past 30 days
  • Willing and able to be contacted for follow-up

Who cannot join

  • Individuals in formal mental health treatment in the past 30 days
  • Have a life-threatening or unstable medical, surgical, or psychiatric condition
  • Inability to provide > 1 form of contact information
  • Anticipate being unable to return for a follow-up assessment
  • Reported active risk of suicide or homicide
  • Fail capacity to consent
  • Cognitively impaired
  • Currently in jail or other overnight facilities as required by courts or law

Trial locations and contacts

2 sites in 1 country. Contact the study team or a site near you to ask about taking part.

Oscar F Rojas Perez, PhD contact

203-940-7869

oscar.rojasperez@yale.edu

United States2 sites, 2 recruiting
  • Fellowship Place

    New Haven, Connecticut, 06511

    Liphahlee (Lee) Marshall, LCSW, 203-401-4227 ext. 1206, lmarshall@fellowshipplace.org

    Oscar F Rojas Perez, PhD

    Recruiting
  • Program for Recovery and Community Health

    New Haven, Connecticut, 06513

    Oscar F Rojas Perez, PhD, 203-940-7869, oscar.rojasperez@yale.edu

    Kimberly Blackman, MSW, (203) 764-8694, kimberly.blackman@yale.edu

    Recruiting

Other trials in United States

About this study

Official title: Abriendo Caminos: Engaging Latino Communities Through Culturally Responsive Peer Delivered Motivational Interviewing

The goal of this clinical trial is to learn if a culturally responsive peer-delivered motivational interviewing intervention can enhance mental health treatment engagement in Latinos with serious mental illness. The main questions it aims to answer are:

  • How feasible is it to recruit 30 Latinos with serious mental illness into a 6 week treatment engagement intervention?
  • How acceptable is the intervention to Latinos with serious mental illness?

Participants will:

  • Receive six sixty-minute sessions
  • Complete weekly measures, along with pre-, post-, 30-day, and 60-day post-intervention assessments
Read the detailed description

Despite the availability of effective mental health treatment, approximately 47% of Latino adults with trauma and serious mental illness (SMI) are not engaged in treatment. The main goal of this current study is to conduct a pilot study to establish the feasibility and acceptability of implementing a culturally responsive motivational interviewing engagement intervention and to ascertain preliminary evidence of the engagement of hypothesized target mechanisms that may mediate enhanced engagement in mental health treatment. The adapted intervention will be implemented by Latino peers with a single cohort (N=30) of Latinos with SMI and not in treatment. Each peer will carry a caseload of 5-6 participants. All participants who meet the inclusion criteria and are interested in participating will complete pre-intervention (baseline), end-of-six-week-intervention, 30-day, and 60-day follow-ups to determine whether there is an increase in treatment engagement, significant changes in measures, and engagement of target mechanisms. Mental health treatment engagement will be measured in multiple ways: 1) as the binary distinction between those who self-report initiation /re-initiation of formal mental health treatment (i.e., outpatient mental health treatment, psychotherapy, medication) within 60 days of the final adapted session 2) and additional indicators of engagement as determined by (e.g., completion of homework, implementation of skills, number of sessions attended). The intervention will approximate the following schedule: session 1 (psychoeducation on SMI and research participation in the current study), session 2 (exploration of strengths and values), session 3 (identification of areas of growth, session 4 (demystifying mental health myths), session 5 (planning for success), and session 6 (planning for growth). The focus is on the change processes-basic motivational interviewing components: awareness of ambivalence about mental health and about change; pros and cons of changing and staying the same; exploration of values and strengths; exploration of possible future; importance and confidence in engaging in treatment; and desire to plan for change.

Being tested
Culturally responsive motivational interviewing
Keywords
SMI, Latino, Peer, Recovery, Engagement

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Culturally responsive motivational interviewingBehavioural

    Six sixty-minute sessions of culturally responsive motivational interviewing, once a week.

Study groups in NCT07529509
Study groupRoleWhat they receive
Culturally responsive peer-delivered motivational interviewingExperimentalSix sixty-minute culturally responsive motivational interviewing sessions, once a week.
Receives: Behavioral: Culturally responsive motivational interviewing

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Number of participants recruited

    The average number of participants recruited to participate in the study

    Measured: From April 2026 to April 2027 (approximately 1 year)

  2. Number of participants that complete the study

    The average number of participants who complete the study

    Measured: From enrollment to the end of follow-up at 60 days post-session 6

  3. Number of sessions completed

    The average number of sessions completed by the participant

    Measured: From enrollment to the end of treatment at 6 weeks

  4. The Client Satisfaction Questionnaire

    The Client Satisfaction Questionnaire (CSQ-8) uses a 4-point Likert scale (1-4) for each item, typically ranging from "Quite dissatisfied" to "Very satisfied" or similar, for a total of 8 to 32 points. High scores indicate greater satisfaction across nine dimensions of service quality.

    Measured: From enrollment to the end of treatment at 6 weeks

  5. Number of assessments completed

    The average number of assessments completed by participants

    Measured: From enrollment to the end of treatment at 6 weeks

  6. Qualitative acceptability questions

    Participants will participate in qualitative interviews regarding their satisfaction with the intervention

    Measured: End of treatment at 6 weeks

Secondary outcomes (16)
  1. Religious Practices and beliefs (RPB 2I)

    The Religious Practices and Beliefs (RPB 2I) is a 13-item instrument scored by recoding responses to establish a zero floor, with higher scores indicating greater religiosity. It measures religious beliefs (0-4) and behavioral frequencies (past year/lifetime) using Likert scales (e.g., 0-7 or 1-3) to assess four dimensions: believing, bonding, behaving, and belonging. To ensure a score floor of zero, responses must be recoded before summing. Generally, this means subtracting 1 from the response value (e.g., if using a 1-8 scale, it becomes 0-7).

    Measured: At enrollment

  2. Marin Short Acculturation Scale for Hispanics (SASH)

    The Marin Short Acculturation Scale for Hispanics (SASH) is a 12-item tool scored by averaging responses, where 1 represents "Only Spanish" and 5 represents "Only English." Higher average scores (closer to 5) indicate higher U.S. acculturation, while lower scores (closer to 1) reflect lower acculturation, and middle scores indicate biculturalism

    Measured: At enrollment

  3. The Multigroup Ethnic Identity Measure-Revised

    The Multigroup Ethnic Identity Measure-Revised (MEIM-R) is a 6-item instrument that uses a 4-point or 5-point Likert scale (e.g., 1=Strongly Disagree to 4/5=Strongly Agree) to measure ethnic identity commitment and exploration. Scoring involves calculating the mean of all items, with higher scores indicating a stronger, more developed ethnic identity

    Measured: At enrollment

  4. Familism Scale

    The Familism Scale is a 14, 5-point Likert scale (1=Very Much in Disagreement, 5=Very Much in Agreement) measuring familism via three subscales: familial obligations, perceived support, and family as referents. Higher scores indicate stronger familism.

    Measured: At enrollment

  5. Life Events Checklist for DSM-5 (LEC-5)

    The Life Events Checklist for DSM-5 (LEC-5) is a 17-item self-report tool measuring lifetime trauma exposure (Criterion A). It screens for events "happened to me," "witnessed it," "learned about it," "part of job," or "not sure," with no official total severity score, but often used to confirm Criterion A for PTSD

    Measured: At enrollment

  6. PCL-5

    The PCL-5 is a 20-item self-report questionnaire assessing DSM-5 PTSD symptoms, scored from 0 ("Not at all") to 4 ("Extremely"), with a total severity score of 0-80. A total score of 31-33 or higher indicates probable PTSD, while a 5-point change represents a response, and 10-20 points indicate clinically meaningful improvement.

    Measured: From enrollment to the end of follow-up at 60 days post-session 6

  7. Perceived Stress

    The Perceived Stress Scale (PSS) is a measure of the degree to which situations in one's life are appraised as stressful. PSS items were designed to tap the degree to which respondents found their lives unpredictable, uncontrollable, and overloading. The PSS comprises 14 items, rated from 0 (never) to 4 (very often). Scores range from 0-56, with higher scores indicating greater perceived stress.

    Measured: From enrollment to the end of follow-up at 60 days post-session 6

  8. Brief Symptom Inventory

    The Brief Symptom Inventory (BSI) is a 53-item self-report tool that measures the intensity of psychological distress (0=not at all, 4=extremely) over seven days. Scores are converted to normalized T-scores (Mean=50, SD=10). A T-score 63 on the Global Severity Index (GSI) or two subscales indicates clinically significant distress; 50-62: moderate-to-high-moderate distress; and < 50: below average or nominal distress.

    Measured: From enrollment to the end of follow-up at 60 days post-session 6

  9. Barriers to Access to Care Evaluation (BACE-3)

    The Barriers to Access to Care Evaluation (BACE-3) is a 30-item self-report tool used to assess attitudinal and structural barriers to seeking mental health services, featuring a 12-item stigma subscale. It utilizes a 4-point Likert scale to measure the extent to what extent items stop, delay, or discourage care, with higher total scores indicating greater barriers to access. Summing all 30 items (ranging from 0 to 90) yields a total barrier burden score.

    Measured: From enrollment to the end of follow-up at 60 days post-session 6

  10. Internalized Stigma of Mental Illness Inventory (ISMI)

    The Internalized Stigma of Mental Illness Inventory (ISMI) is a 29-item self-report questionnaire scoring 1-4 per item, used to measure subjective self-stigma. A mean total score (sum of items divided by number of items) ranging from 1 to 4 is calculated. A higher mean score indicates greater internalized stigma, typically categorized into minimal (1.0-2.0), mild (2.01-2.5), moderate (2.51-3.0), or severe (>3.0).

    Measured: From enrollment to the end of follow-up at 60 days post-session 6

  11. University of Rhode Island Change Assessment Scale (URICA)

    The University of Rhode Island Change Assessment Scale (URICA) is a 32-item self-report tool evaluating motivation to change using a 5-point Likert scale (1=Strongly Disagree to 5=Strongly Agree). It calculates scores for four stages-Precontemplation, Contemplation, Action, and Maintenance-which can be used independently or combined into a continuous "Readiness to Change" formula. Higher scores indicate greater readiness to change. Respondents can score high on more than one stage, reflecting that the stages of change are not always discrete

    Measured: From enrollment to the end of follow-up at 60 days post-session 6

  12. Empowerment

    The Rogers Empowerment Scale is a 28-item self-report tool designed to measure mental health service user empowerment across five factors. It uses a 4-point Likert scale (1=Strongly Agree, 4=Strongly Disagree), with total scores ranging from 28 to 112, where higher scores indicate greater empowerment.

    Measured: From enrollment to the end of follow-up at 60 days post-session 6

  13. WHO Quality of Life Brief

    The WHOQOL-BREF is scored by calculating the mean score for each of the four domains (Physical, Psychological, Social, Environment), and multiplying by 4 to create a 4-20 scale. Finally, these scores are often transformed to a 0-100 scale, where higher scores indicate a higher quality of life. Scores are typically presented as a profile of the four domains rather than a single total score.

    Measured: From enrollment to the end of follow-up at 60 days post-session 6

  14. Working Alliance Inventory Client - Short Revised (WAI-SR-C)

    The Working Alliance Inventory - Short Revised Client version (WAI-SR-C) is a 12-item self-report questionnaire assessing the therapy bond, goals, and tasks. Clients rate items on a 5-point Likert scale (1 = Seldom to 5 = Always), with higher total scores (12-60) indicating a stronger therapeutic alliance.

    Measured: From enrollment to the end of treatment at 6 weeks

  15. Working Alliance Inventory Therapist - Short Revised (WAI-SR-T)

    The Working Alliance Inventory - Short Revised - Therapist (WAI-SR-T) is a 12-item self-report questionnaire that measures a therapist's perspective on the alliance with their client. It uses a 5-point Likert scale (1 = Seldom to 5 = Always) to score three subscales (Bond, Goals, Tasks). The total score ranges from 12 to 60, with higher scores reflecting a stronger alliance.

    Measured: From enrollment to the end of treatment at 6 weeks

  16. Treatment engagement

    Binary (yes or no) engaged in treatment

    Measured: From enrollment to the end of follow-up at 60 days post-session 6

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted14 Apr 2026
  2. Study start9 Jul 2026
  3. Primary completionApr 2027 (estimated)
  4. Study completionAug 2027 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Supportive care
Allocation
Not applicable
Intervention model
Single group
Model description
The six sessions are: session 1 (psychoeducation on SMI and research participation in the current study), session 2 (exploration of strengths and values), session 3 (identification of areas of growth, session 4 (demystifying mental health myths), session 5 (planning for success), and session 6 (planning for growth). The sessions will be delivered by a Latino peer with lived experience.
Masking
None (open label)
Enrolment
30 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT07529509
Sponsor's protocol ID
2000034687
Other IDs
5K23MH130718
Acronym
AC
Status last verified
Jul 2026
First submitted
7 Apr 2026
Last updated
21 Jul 2026
Results posted
No
Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No: Given that the sample is small and coming from a small town, it is possible we run the risk of participants being identified.

Publications

  • Repper J, Carter T. A review of the literature on peer support in mental health services. J Ment Health. 2011 Aug;20(4):392-411. doi: 10.3109/09638237.2011.583947.

    PubMed 21770786
  • Eichele G. Retinoic acid induces a pattern of digits in anterior half wing buds that lack the zone of polarizing activity. Development. 1989 Dec;107(4):863-7. doi: 10.1242/dev.107.4.863.

    PubMed 2632237
  • Lenhoff SJ, Horak AR, Fraser RC, Scott-Millar RN, Bird AR, Jacobs P, Commerford PJ. Evaluation of the efficacy and safety of anisoylated plasminogen streptokinase activator complex in early myocardial infarction. Preliminary results. Drugs. 1987;33 Suppl 3:186-8. doi: 10.2165/00003495-198700333-00032. No abstract available.

    PubMed 3315590
  • Friedman TC, Kline TB, Wilk S. 5-Oxoprolinal: transition-state aldehyde inhibitor of pyroglutamyl-peptide hydrolase. Biochemistry. 1985 Jul 16;24(15):3907-13. doi: 10.1021/bi00336a015.

    PubMed 2864952
  • Rabinowitz M, Leviton A, Bellinger D. Home refinishing, lead paint, and infant blood lead levels. Am J Public Health. 1985 Apr;75(4):403-4. doi: 10.2105/ajph.75.4.403.

    PubMed 3976969
  • Faulkner RS, Van Rooyen CE. Two new candidate enterovirus serotypes, isolated from CSF. Am J Epidemiol. 1969 Jan;89(1):110-5. doi: 10.1093/oxfordjournals.aje.a120909. No abstract available.

    PubMed 4303048
  • Maura J, Weisman de Mamani A. Mental Health Disparities, Treatment Engagement, and Attrition Among Racial/Ethnic Minorities with Severe Mental Illness: A Review. J Clin Psychol Med Settings. 2017 Dec;24(3-4):187-210. doi: 10.1007/s10880-017-9510-2.

    PubMed 28900779
  • Ramos Z, Alegria M. Cultural adaptation and health literacy refinement of a brief depression intervention for Latinos in a low-resource setting. Cultur Divers Ethnic Minor Psychol. 2014 Apr;20(2):293-301. doi: 10.1037/a0035021. Epub 2014 Mar 3.

    PubMed 24588455
  • Kanter JW, Santiago-Rivera AL, Rusch LC, Busch AM, West P. Initial outcomes of a culturally adapted behavioral activation for Latinas diagnosed with depression at a community clinic. Behav Modif. 2010 Mar;34(2):120-44. doi: 10.1177/0145445509359682. Epub 2010 Feb 22.

    PubMed 20176914
  • Valman HB. ABC of 1 to 7: whooping cough. Br Med J (Clin Res Ed). 1982 Mar 20;284(6319):886-7. doi: 10.1136/bmj.284.6319.886. No abstract available.

    PubMed 6802339
  • Matveeva LA. [Dynamics of erythrocytes and some indices in healthy individuals and in children with acute pneumonia]. Pediatriia. 1973 Sep;52(9):51. No abstract available. Russian.

    PubMed 4780300
  • Mueser KT, Salyers MP, Rosenberg SD, Goodman LA, Essock SM, Osher FC, Swartz MS, Butterfield MI; 5 Site Health and Risk Study Research Committee. Interpersonal trauma and posttraumatic stress disorder in patients with severe mental illness: demographic, clinical, and health correlates. Schizophr Bull. 2004;30(1):45-57. doi: 10.1093/oxfordjournals.schbul.a007067.

    PubMed 15176761
  • Rivera-Segarra E, Varas-Diaz N, Santos-Figueroa A. "That's all Fake": Health professionals stigma and physical healthcare of people living with Serious Mental Illness. PLoS One. 2019 Dec 18;14(12):e0226401. doi: 10.1371/journal.pone.0226401. eCollection 2019.

    PubMed 31851706
  • Corrigan P, Sheehan L, Morris S, Larson JE, Torres A, Lara JL, Paniagua D, Mayes JI, Doing S. The Impact of a Peer Navigator Program in Addressing the Health Needs of Latinos With Serious Mental Illness. Psychiatr Serv. 2018 Apr 1;69(4):456-461. doi: 10.1176/appi.ps.201700241. Epub 2017 Dec 15.

    PubMed 29241431

Questions about this trial

What is this clinical trial studying?

A study testing Culturally responsive motivational interviewing in people with Serious Mental Illness, run by Yale University at 2 sites in United States.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 9 inclusion and 8 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: looking for participants now, as of the sponsor's last update on 21 Jul 2026. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 2 sites in United States. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

This study is still under way. Results are not available in the source record yet.

How can a doctor refer a patient or contact the research team?

Contact Oscar F Rojas Perez, PhD (203-940-7869, oscar.rojasperez@yale.edu), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Number of participants recruited (time frame: From April 2026 to April 2027 (approximately 1 year)). The study lists 6 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT07529509, which also lists 14 linked publications.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 21 Jul 2026.

Free account

Keep searching with a free account

You’ve used your 3 free searches for this session. Log in or create a free AzTrials account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in